On ECHEMI
Home > Drugs > Brinzolamide Registered Holders
Brinzolamide structure

Brinzolamide structure

Brinzolamide

Crystalline SolidBrinzolamide was introduced as Azopt in the US for the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or openangle glaucoma. Brinzolamide is a potent inhibitor of human carbonic anhydrase Ⅱ lowering IOP after topical administration . It is the second of this class after dorzolamide (1995). Brinzolamide can be prepared in an eight-step sequence from 3-acetyl-2,5-dichlorothiophene. In patients with primary open-angle glaucoma or ocular

Find 8 Related Holders

PHARMATHEN SA
United States United States

API Registration Country

API Active
DUKE CHEM S.A.U.
Japan Japan

API Registration Country

API Active
SCI PHARMTECH INC
United States United States

API Registration Country

API Active
SCI Pharmtech, Inc.
Japan Japan

API Registration Country

API Active
ICROM S.r.l.
Japan Japan

API Registration Country

API Active
BACHEM S.A.
Argentina Argentina

API Registration Country

API Inactive
  • Founded in:

    2006-03-30 00:00:00
  • Country:

    Argentina Argentina
  • Address:

    PRIMERA JUNTA 1406, Piso 5, 1406 CAPITAL FEDERAL, CIUDAD AUTONOMA BUENOS AIRES
  • Email:

Biobetta Pharmaceuticals (Shanghai) Co., Ltd.
China China

API Registration Country

API Inactive
  • Founded in:

    2016-07-15
  • Country:

    China China
  • Address:

    Room C- 22, Floor 4, Building 1, 198 Huashen Road, China (Shanghai) Pilot Free Trade Zone
  • Tax NO.:

    91310115MA1K3EF230
  • Registered Funds:

    $1 million
  • Website:

  • Email:

Xufu Pharmaceutical Technology Co., Ltd. Taoyuan Factory
China China

API Registration Country

API Inactive
Recommended Suppliers of Brinzolamide
View 81 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.